**Core Concept:** Clinical trials are a vital part of the drug development process, where the safety, efficacy, and optimal dosage of a drug are assessed in humans. They are typically divided into four phases: Phase I, II, III, and IV.

**Why the Correct Answer is Right:** Phase I trials involve healthy normal human volunteers to test the safety, pharmacokinetics, and pharmacodynamics of a new drug. The goal is to identify potential side effects, drug interactions, and optimal dosage range. This is crucial for ensuring the drug is safe for patients with diseases before progressing to more specific patient populations in later phases.

**Why Each Wrong Option is Incorrect:**

A. **Phase II trials:** These trials involve patients with the targeted disease or condition to assess the drug's efficacy and optimal dosage. Healthy volunteers are not involved during this phase.

B. **Phase III trials:** This phase involves a larger number of patients with the targeted disease or condition to confirm the drug's efficacy, compare it to existing treatments, and assess its safety profile. Healthy volunteers are not involved during this phase.

C. **Phase IV trials:** These post-marketing trials monitor the drug's safety, effectiveness, and side effects in a large number of patients after the drug is approved and released for general use. Healthy volunteers are not involved during this phase.

D. **Phase I trials:** Although correct, this answer is redundant, as the correct answer already explains the purpose of Phase I trials.

**Clinical Pearl:** In clinical trials, the choice of study participants is crucial to ensure the safety and efficacy of a drug. Healthy volunteers in Phase I trials provide vital information about drug safety and dosage, which is essential before involving patients in later phases. This ensures that potential side effects and optimal dosage are established before administering the drug to patients with the target condition.